Endoglin Promotes Angiogenesis in Cell- and Animal-Based Models of Retinal Neovascularization
Authors:
Open Access
- 1 October 2014
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 55 (10) , 6490-6498
Abstract
Purpose.: We investigated endoglin expression in hypoxic microvascular endothelial cells and retinal endoglin expression in rats that develop experimental oxygen-induced retinopathy (OIR). We also tested neutralizing antibodies (Abs) against endoglin (anti-CD105 Ab) and VEGF (anti-VEGF Ab) either alone or in combination for efficacy against serum-induced retinal microvascular endothelial cell proliferation and retinal neovascularization (NV) in OIR rats. To our knowledge, this marks the first time that a biologic agent has been used to target retinal endoglin and modulate retinal neovascularization. Methods.: Induction of endoglin by hypoxia was measured by immunohistochemical analysis and ELISA. Proliferation was quantified using a colorimetric 5-bromo-2-deoxyuridine ELISA. Western blots were used to measure endoglin levels in retinas of OIR rats. Immunohistochemical staining was also preformed in OIR rats using anti-CD105 and fluorescein isothiocyanate-conjugated isolectin B4 antibodies. Results.: Anti-CD105 Ab and Anti-VEGF Ab, administered alone or in combination, reduced serum-induced retinal microvascular endothelial cell proliferation. Additionally, in a rat model of oxygen-induced retinopathy, retinal endoglin was significantly increased at 14(2), 14(3), 14(4) and 14(6) compared with retinal levels in control rats. At 14(2), immunohistochemical analysis demonstrated that endoglin was elevated in newly developed vessels at the peripheral extent of major veins, precisely where NV is expected to develop in OIR rats. Neutralizing anti-CD105 reduced retinal NV in OIR rats. Conclusions.: Our data support other studies showing that reduction of endoglin expression inhibits retinal NV. Our findings demonstrate that retinal endoglin immunolocalization overlaps with nascent neovascular structures in OIR rats. Therefore, endoglin may serve as a useful predictor of incipient neovascular disease.Keywords
This publication has 64 references indexed in Scilit:
- SRPK1 Inhibition Modulates VEGF Splicing to Reduce Pathological Neovascularization in a Rat Model of Retinopathy of PrematurityInvestigative Ophthalmology & Visual Science, 2013
- Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigrationBlood, 2013
- Role of Cytosolic Phospholipase A2in Retinal NeovascularizationInvestigative Ophthalmology & Visual Science, 2010
- Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathyThe International Journal of Biochemistry & Cell Biology, 2009
- Anti‐endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculatureInternational Journal of Cancer, 2009
- Anti-vascular endothelial growth factor therapy for ocular neovascular diseaseCurrent Opinion in Ophthalmology, 2007
- Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesionsBritish Journal of Ophthalmology, 2007
- Retinopathy of prematurityAngiogenesis, 2007
- Inhibitors of Ocular NeovascularizationJAMA, 2005
- In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11Anti-Cancer Drugs, 1997